NCT06648837 - Microvisk Continuous Blood Donation Study | Biotech Hunter

Enrollment

2,500

Participants

Timeline

Start Date

January 13, 2025

Primary Completion Date

October 30, 2029

Study Completion Date

November 1, 2029

Conditions

Pulmonary Embolism (Diagnosis)Deep Vein ThrombosisAtrial Fibrillation (AF)

Interventions

PROCEDURE

Venepuncture

Venepuncture to collect blood samples from Patients undergoing Warfarin Therapy, additional tubes of blood drawn during normal clinical vist.

OTHER

Collection of relevant information

Collect relevant information to ensure potential participant meets all inclusion/exclusion criteria.

Trial Locations (1)

Oxford Haemophilia and Thrombosis Centre, Oxford